TLR2 and Alzheimer disease: It has also been reported that the abnormal expression of TLR1 and TLR2 can be normalized after a 3-week treatment with tacrolimus ointment [123], suggesting that TCIs may exert their therapeutic effects by restoring normal function of TLR2 signaling in AD.